文献速递胸部儿科影像CTDR

青少年电子烟或雾化产品使用相关肺损伤:影像学特征综述

E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features.
PubMed 文献 · Pediatr Radiol · 2020-01-02

该研究回顾了3个月内本院12例有电子烟使用史的青少年急性呼吸道疾病患者,总结其胸部影像表现。CT均见磨玻璃影,92%见小叶中心磨玻璃结节,75%见胸膜下豁免,提示EVALI的典型影像模式。

要点

  • 青少年急性呼吸道症状伴小叶中心磨玻璃结节和磨玻璃影、胸膜下豁免时,需考虑EVALI。
  • 12例CT中磨玻璃影100%、小叶中心磨玻璃结节92%、胸膜下豁免75%。
  • 因青少年可能隐瞒电子烟使用史,儿科放射科医生应熟悉该病的影像模式。

关键影像表现/征象

  • 12例均行胸部CT,12/12(100%)见融合性磨玻璃影,11/12(92%)见小叶中心磨玻璃结节。
  • 9/12(75%)见胸膜下豁免,6/12(50%)见少量胸腔积液,6/12(50%)见轻度支气管壁增厚。
  • 9/12(75%)见肺门或纵隔淋巴结增大,2/12(17%)见少量心包积液。

诊断标准与关键数值

  • 12例中4/12(33%)肺功能见弥散功能降低,4/12(33%)见阻塞性通气模式,1/12(8%)见限制性模式,2/12(17%)见混合性阻塞和限制性模式。
  • 9/12例行支气管肺泡灌洗,显示炎症细胞和载脂蛋白巨噬细胞。

临床应用与阅片要点

  • 儿科放射科医生应熟悉小叶中心磨玻璃结节、磨玻璃影伴胸膜下豁免这一EVALI影像模式。
  • 青少年可能不主动提供电子烟使用史,影像发现上述模式时应考虑本病可能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: There has been a recent increase in recognition of lung disease related to the use of electronic cigarettes (called "vaping"). These patients present with acute respiratory illness following exposure to vaporized cannabis or nicotine products and sometimes require hospitalization and intensive care. We describe the imaging findings of this disease entity in the pediatric population.

OBJECTIVE: To describe the radiologic findings of lung injury associated with electronic cigarette use (vaping) in the adolescent pediatric population.

MATERIALS AND METHODS: We identified all adolescents with acute respiratory illness and a history of electronic cigarette use who presented at our institution within a 3-month period (June 2019 through August 2019). We excluded adolescents with potential intercurrent pulmonary disease. We reviewed the charts for symptomatology and laboratory and pathology data. In addition, we reviewed the chest radiographs and chest CTs of these adolescents.

RESULTS: The review group consisted of 12 teenage pediatric patients (10 boys and 2 girls; mean age 16.9 years, range 16.0-17.7 years) with acute respiratory illness found to have a temporal association with electronic cigarette use for cannabis products, nicotine, or both. Other etiologies for illness in these adolescents had been excluded by clinical and laboratory evaluation. All of the adolescents were admitted to the hospital for treatment. The clinical presentations included dyspnea, abdominal pain and constitutional symptoms. Pulmonary function testing that was performed in all patients during admission or follow-up demonstrated reduced diffusion capacity in 4/12 (33%), an obstructive ventilatory pattern in 4/12 (33%), a restrictive pattern in 1/12 (8%), and a mixed obstructive and restrictive pattern in 2/12 (17%) adolescents. Bronchoalveolar lavage studies, performed in 9 of the 12 adolescents, revealed inflammatory cells and lipid-laden macrophages. All of the patients underwent CT of the chest; the findings were notable for centrilobular ground-glass nodules (11/12; 92%) and confluent ground-glass opacities (12/12; 100%), with frequent subpleural sparing (9/12; 75%). Additionally, 6/12 (50%) adolescents demonstrated small pleural effusions; 6/12 (50%) had mild bronchial wall thickening; 9/12 (75%) had enlarged hilar or mediastinal lymph nodes; and 2/12 (17%) had a small pericardial effusion.

CONCLUSION: As seen in our teenage population, e-cigarette, or vaping, product use-associated lung injury (EVALI) is characterized by centrilobular ground-glass nodules and ground-glass opacities with subpleural sparing. The imaging findings are most consistent with acute lung injury resulting from toxic inhalation. Because adolescent pediatric patients might not be forthcoming with their history of electronic cigarette use, it is important for the pediatric radiologist to be aware of the imaging patterns of this disease.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Thakrar PD, Boyd KP, Swanson CP, et al. E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol. 2020. PMID: 31897566. doi:10.1007/s00247-019-04572-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。